CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Apr. 30, 2014	Apr. 30, 2013
Cash flows from operating activities:
Net income	$ 21,230	$ 387,540
Net income items not affecting cash:
Depreciation and amortization	17,675	4,698
Stock-based compensation	9,818	7,106
Issuance of stock to board member for advisory services	47,000	20,000
Issuance of stock to investment firm	50,000	0
Issuance of Preferred A stock to Officer	2,950	0
Increase in bad debt reserve	0	483
Increase in reserve for inventory loss	5,471	7,754
Increase / (Decrease) in operating assets:
Accounts receivable	(253,805)	216,255
Inventory	11,706	89,296
Prepaid expense	81,868	(29,212)
Decrease / (Increase) in operating liabilities:
Accounts payable - trade	45,434	28,211
Accrued payable - other	(13,286)	(23,080)
Unearned revenue	(370,100)	(215,004)
Net cash provided by (used in) operating activities	(344,039)	494,047
Cash flows from investing activities:
Capital expenditures	(106,514)	(1,075)
Net cash used in investing activities	(106,514)	(1,075)
Cash flows from financing activities:
Proceeds from sale of common stock	25,000	0
Proceeds from notes payable	77,894	0
Payments on notes payable	0	(54,000)
Net cash provided by (used in) financing activities	102,894	(54,000)
Net increase (decrease) in cash and cash equivalents	(347,659)	438,972
Cash and cash equivalents, beginning of period	596,871	249,327
Cash and cash equivalents, end of period	249,212	688,299
Supplemental information:
Income taxes paid	0	0
Interest paid	$ 1,965	$ 0